VEGFA and chronic kidney disease: Patients with CKD had a higher probability of developing hypercholesterolemia-related kidney damage, including decreased expression of vascular endothelial growth factor and graft dysfunction [48], as well as ectopic lipid accumulation in the kidney and its clinical impact except for steatosis of the liver.